Clinical Trial Update: Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers [Phase 2]

View source ↗

Summary

A multicenter Phase 2 clinical trial evaluating Envafolimab for biliary tract cancers is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: 3D Medicines (Sichuan) Co., Ltd. | Conditions: Biliary Tract Neoplasms | Phase 2 | Status: NOT_YET_RECRUITING